Laboratory reproducibility of biochemical markers of bone turnover in clinical practice

Osteoporosis International

Volumn 21, Issue 3, 2010, Pages 439-445

  Schafer, A L ^a,d   Vittinghoff, E ^a   Ramachandran, R ^b   Mahmoudi, N ^c   Bauer, D C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAISER PERMANENTE   (United States)

^d NONE   (United States)

Author keywords

Bone turnover markers; Bone specific alkaline phosphatase; Laboratory assay; Reproducibility; Urine N telopeptide

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BIOASSAY; BLOOD SAMPLING; BONE TURNOVER; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; REPRODUCIBILITY; URINALYSIS;

AGED; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE REMODELING; COLLAGEN TYPE I; FEMALE; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MIDDLE AGED; PEPTIDES; POSTMENOPAUSE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 76549108264     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-009-0974-2     Document Type: Article

References (17)

1. P Garnero WJ Shih E Gineyts DB Karpf PD Delmas 1994 Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment J Clin Endocrinol Metab 79 1693 1700 10.1210/jc.79.6.1693 1:CAS:528:DyaK2MXislWiuro%3D 7989477
2. P Ravn D Hosking D Thompson G Cizza RD Wasnich M McClung AJ Yates NH Bjarnason C Christiansen 1999 Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study J Clin Endocrinol Metab 84 2363 2368 10.1210/jc.84.7.2363 1:CAS:528:DyaK1MXks1agtb8%3D 10404804 (Pubitemid 30670863)
3. R Eastell I Barton RA Hannon A Chines P Garnero PD Delmas 2003 Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate J Bone Miner Res 18 1051 1056 10.1359/jbmr.2003.18.6.1051 1:CAS:528:DC%2BD3sXkslOhsb0%3D 12817758 (Pubitemid 37294942)
4. JY Reginster S Sarkar B Zegels Y Henrotin O Bruyere D Agnusdei J Collette 2004 Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk Bone 34 344 351 10.1016/j.bone.2003.10.004 1:CAS:528:DC%2BD2cXhtFWms74%3D 14962813 (Pubitemid 38177616)
5. DC Bauer DM Black P Garnero M Hochberg S Ott J Orloff DE Thompson SK Ewing PD Delmas Fracture Intervention Trial Study Group 2004 Changes in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial J Bone Miner Res 19 1250 1258 10.1359/JBMR.040512 15231011 (Pubitemid 41094365)
6. Fraser WD, Anderson M, Chesters C, Durham B, Ahmad AM, Chattington P, Vora J, Squire CR, Diver MJ (2001) Circadian rhythm studies of serum bone resorption markers: implications for optimal sample timing and clinical utility. In: Eastell R, Baumann M, Hoyle NR, Wieczorek L (eds) Bone markers: biochemical and clinical perspectives. Martin Dunitz, London, pp 107-118
7. MJ Seibel M Lang WJ Geilenkeuser 2001 Interlaboratory variation of biochemical markers of bone turnover Clin Chem 47 1443 1450 1:CAS:528: DC%2BD3MXls1SqurY%3D 11468235
8. MG Vangel 1996 Confidence intervals for a normal coefficient of variation Am Stat 50 21 26 10.2307/2685039
9. CJ Feltz GE Miller 1996 An asymptotic test for the equality of coefficients of variation from k populations Stat Med 15 647 658 10.1002/(SICI)1097-0258(19960330)15:6<647::AID-SIM184>3.0.CO;2-P (Pubitemid 26109011)
10. MJ Seibel HW Woitge I Farahmand H Oberwittler R Ziegler 1998 Automated and manual assays for urinary crosslinks of collagen: which assay to use? Exp Clin Endocrinol Diabetes 106 143 148 10.1055/s-0029-1211967 1:CAS:528: DyaK1cXislyjsrg%3D 9628247
11. HW Vesper SJ Smith C Audain GL Myers 2001 Comparison study of urinary pyridinoline and deoxypyridinoline measurements in 13 US laboratories Clin Chem 47 2029 2031 1:CAS:528:DC%2BD3MXnvF2jurk%3D 11673372
12. N Binkley D Krueger CS Cowgill L Plum E Lake KE Hansen HF DeLuca MK Drezner 2004 Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization J Clin Endocrinol Metab 89 3152 3157 10.1210/jc.2003-031979 1:CAS:528:DC%2BD2cXlslegsr0%3D 15240586 (Pubitemid 38951877)
13. N Binkley D Krueger D Gemar MK Drezner 2008 Correlation among 25-hydroxy-vitamin D assays J Clin Endocrinol Metab 93 1804 1808 10.1210/jc.2007-2340 1:CAS:528:DC%2BD1cXlvFWgsLk%3D 18319318 (Pubitemid 351656521)
14. BW Hollis 2004 The determination of circulating 25-hydroxyvitamin D: no easy task J Clin Endocrinol Metab 89 3149 3151 10.1210/jc.2004-0682 1:CAS:528:DC%2BD2cXlslegsrw%3D 15240585 (Pubitemid 38951876)
15. LA Tortajada-Genaro MP Cózar JL Frigols CR de Avila 2007 Comparison of immunoradiometric assays for determination of thyroglobulin: a validation study J Clin Lab Anal 21 147 153 10.1002/jcla.20156 1:CAS:528:DC%2BD2sXmslOjs74%3D 17506473 (Pubitemid 46808906)
16. P Holvoet E Macy M Landeloos D Jones NS Jenny F Van de Werf RP Tracy 2006 Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL Clin Chem 52 760 764 10.1373/clinchem.2005.064337 1:CAS:528:DC%2BD28Xjt1Gqsrk%3D 16497937
17. JS Lee B Ettinger FZ Stanczyk E Vittinghoff V Hanes JA Cauley W Chandler J Settlage MS Beattie E Folkerd M Dowsett D Grady SR Cummings 2006 Comparison of methods to measure low serum estradiol levels in postmenopausal women J Clin Endocrinol Metab 91 3791 3797 10.1210/jc.2005-2378 1:CAS:528:DC%2BD28XhtFSjtLfE 16882749 (Pubitemid 44536845)